SU1574178A3 - Способ получени производных 4-замещенного андростендиона, или их фармацевтически приемлемых солей - Google Patents

Способ получени производных 4-замещенного андростендиона, или их фармацевтически приемлемых солей Download PDF

Info

Publication number
SU1574178A3
SU1574178A3 SU864021024A SU4021024A SU1574178A3 SU 1574178 A3 SU1574178 A3 SU 1574178A3 SU 864021024 A SU864021024 A SU 864021024A SU 4021024 A SU4021024 A SU 4021024A SU 1574178 A3 SU1574178 A3 SU 1574178A3
Authority
SU
USSR - Soviet Union
Prior art keywords
formula
dione
compound
bond
compounds
Prior art date
Application number
SU864021024A
Other languages
English (en)
Russian (ru)
Inventor
Фаустини Франко
Дъалессио Роберто
Вилла Виттория
Ди Салле Энрико
Ломбарди Паоло
Original Assignee
Фармиталиа Карло Эрба С.Р.Л.(Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Фармиталиа Карло Эрба С.Р.Л.(Фирма) filed Critical Фармиталиа Карло Эрба С.Р.Л.(Фирма)
Application granted granted Critical
Publication of SU1574178A3 publication Critical patent/SU1574178A3/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0027—Azides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SU864021024A 1985-02-15 1986-02-14 Способ получени производных 4-замещенного андростендиона, или их фармацевтически приемлемых солей SU1574178A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858503940A GB8503940D0 (en) 1985-02-15 1985-02-15 4-substituted androstendione derivatives

Publications (1)

Publication Number Publication Date
SU1574178A3 true SU1574178A3 (ru) 1990-06-23

Family

ID=10574550

Family Applications (1)

Application Number Title Priority Date Filing Date
SU864021024A SU1574178A3 (ru) 1985-02-15 1986-02-14 Способ получени производных 4-замещенного андростендиона, или их фармацевтически приемлемых солей

Country Status (28)

Country Link
US (1) US4757061A (fi)
JP (1) JPS61189295A (fi)
KR (1) KR930005994B1 (fi)
AT (1) AT396239B (fi)
AU (1) AU577667B2 (fi)
BE (1) BE904226A (fi)
CA (1) CA1319362C (fi)
CH (1) CH669199A5 (fi)
CZ (1) CZ413691A3 (fi)
DE (1) DE3604179A1 (fi)
DK (1) DK167221B1 (fi)
ES (2) ES8706165A1 (fi)
FI (1) FI84272C (fi)
FR (1) FR2577556B1 (fi)
GB (2) GB8503940D0 (fi)
GR (1) GR860430B (fi)
HK (1) HK94090A (fi)
HU (1) HU194909B (fi)
IE (1) IE58864B1 (fi)
IT (1) IT1190335B (fi)
MY (1) MY102038A (fi)
NL (1) NL8600383A (fi)
NZ (1) NZ215163A (fi)
PT (1) PT82030B (fi)
SE (2) SE468515B (fi)
SG (1) SG80890G (fi)
SU (1) SU1574178A3 (fi)
ZA (1) ZA861118B (fi)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8622330D0 (en) * 1986-09-17 1986-10-22 Erba Farmitalia 4-substituted 6-alkylidenandrostene-3,17-dione derivatives
GB8624251D0 (en) * 1986-10-09 1986-11-12 Erba Farmitalia "1,2-beta-methylene-4-substituted androstene-3,17 dione derivatives
DE3711772A1 (de) * 1987-04-08 1988-10-27 Schering Ag 4- und 15-disubstituierte 4-androsten-3,17-dione und verfahren zu deren herstellung
GB8711579D0 (en) * 1987-05-15 1987-06-17 Erba Farmitalia 4-amino-androstenedione derivatives
US5595985A (en) 1989-03-10 1997-01-21 Endorecherche Inc. Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia
JP3332377B2 (ja) * 1989-07-07 2002-10-07 アンドルシェルシュ・インコーポレイテッド 良性前立腺過形成の予防および／または治療のための組合せ療法
US5143909A (en) * 1991-03-19 1992-09-01 Merrell Dow Pharmaceuticals Inc. Aminosteroids in a method for inhibiting c17-20 lyase
US5120840A (en) * 1990-08-01 1992-06-09 Merrell Dow Pharmaceuticals Inc. 4-amino-4-ene-steroids and their use as 5α-reductase inhibitors
AU637247B2 (en) * 1990-08-01 1993-05-20 Merrell Dow Pharmaceuticals Inc. 4-amino-delta4-steroids and their use as 5alpha-reductase inhibitors
US5130424A (en) * 1990-08-01 1992-07-14 Merrell Dow Pharmaceuticals Inc. 4-amino-delta-4,6-steroids and their use as 5 alpha-reductase inhibitors
NZ239141A (en) * 1990-08-01 1994-04-27 Merrell Dow Pharma 4-amino-delta-4,6-steroids; preparatory processes and pharmaceutical compositions
US5218110A (en) * 1990-08-01 1993-06-08 Merrell Dow Pharmaceuticals 4-amino-Δ4 -steroids and their use as 5α-reductase inhibitors
US5318961A (en) * 1990-08-01 1994-06-07 Merrell Dow Pharmaceuticals Inc. 4-amino-Δ4-steroids and their use as 5α-reductase inhibitors
US5162337A (en) * 1990-10-05 1992-11-10 Merck & Co., Inc. Animal growth promotion
US5189032A (en) * 1991-03-19 1993-02-23 Merrell Dow Pharmaceuticals Inc. 4-amino-Δ4,6 -steroids and their use as 5α-reductase inhibitors
KR0180008B1 (ko) * 1991-03-28 1999-04-01 야마구찌 다까시 신규 옥사-또는 아자스테로이드 유체
CH683151A5 (de) * 1991-04-24 1994-01-31 Ciba Geigy Ag Antikonzeption bei weiblichen Primaten ohne Beeinflussung des menstruellen Zyklus.
GB9111260D0 (en) * 1991-05-24 1991-07-17 Erba Carlo Spa Process for the preparation of 4-amino-unsaturated androstanedione derivatives
GB9217035D0 (en) * 1992-08-11 1992-09-23 Erba Carlo Spa Androst-4-eno(4,5-b)pyrrole derivatives and process for their preparation
HU221191B1 (en) * 1992-09-30 2002-08-28 Teikoku Hormone Mfg Co Ltd 7-substituted oxasteroid compounds, process for their preparation and pharmaceutical compositions containing the same
EP0636138A1 (en) * 1993-02-18 1995-02-01 PHARMACIA & UPJOHN S.p.A. Fluorinated 4-aminoandrostadienone derivatives and process for their preparation
US5486511A (en) * 1993-05-25 1996-01-23 Merrell Dow Pharmaceuticals Inc. 4-amino-17β-(cyclopropyloxy)androst-4-en-3-one, 4-amino-17β-(cyclopropylamino)androst-4-en-3-one and related compounds as C17-20 lyase and 5α-reductase
US6407082B1 (en) * 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
GB2284605A (en) * 1993-12-09 1995-06-14 Erba Carlo Spa 6-or 7-substituted 4-aminoandrostadienone derivatives
AU686793B2 (en) * 1994-05-02 1998-02-12 Merrell Pharmaceuticals Inc. Process for the preparation of 4-amino- 4-3-ketosteroids via 4-nitro-delta 4-3-ketosteroids
US6365597B1 (en) 1996-02-14 2002-04-02 Aventis Pharmaceuticals Inc. 4-aza steroids
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
US6034074A (en) 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
US6028064A (en) 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US7435757B2 (en) * 2004-07-02 2008-10-14 Schering Ag 2-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17β-hydroxy steroid dehydrogenase type 1

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1042291A (en) * 1961-11-08 1966-09-14 Organon Labor Ltd í¸-6ª‡-amino steroids and the preparation thereof
DE1203768B (de) * 1962-02-01 1965-10-28 Merck Ag E Verfahren zur Herstellung von N-substituierten 4-Aminosteroiden der Testosteronreiheund Saeureadditionssalzen derselben
DE1668690C3 (de) * 1968-02-29 1978-09-14 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Herstellung von N-substituierten 4-Aminosteroiden der Androstan-Pregnan- und Cholestanreihe
DK120154B (da) * 1968-02-29 1971-04-19 Schering Ag Fremgangsmåde til fremstilling af N-substituerede 4-amino-3-oxosteroid-4,6-diener af androstan- eller pregnanrækken eller deres ammoniumsalte.
US3780070A (en) * 1972-09-21 1973-12-18 Schering Corp 4-azido-17alpha-alkinyl-4-gonen-17beta-ol-3-ones and method for their preparation
CA1154008A (en) * 1979-05-02 1983-09-20 Thomas R. Blohm STEROID 5.alpha.-REDUCTASE INHIBITORS

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Кэмпб елл Дж.А. , Бэбкок Дж.К., I. An. Chem. Soc., 81, 4069, 1959. Djerassi. Steroids San Fran, 1963, p.232. *

Also Published As

Publication number Publication date
DK167221B1 (da) 1993-09-20
DK71486A (da) 1986-08-16
FR2577556A1 (fr) 1986-08-22
FI84272B (fi) 1991-07-31
SE8600668L (sv) 1986-08-16
CA1319362C (en) 1993-06-22
JPH0469638B2 (fi) 1992-11-06
GB2171100B (en) 1988-11-30
US4757061A (en) 1988-07-12
ATA38886A (de) 1992-11-15
IE860413L (en) 1986-08-15
IT8619361A0 (it) 1986-02-11
ES8708235A1 (es) 1987-10-01
DK71486D0 (da) 1986-02-14
AU5343386A (en) 1986-08-21
KR860006485A (ko) 1986-09-11
HUT40454A (en) 1986-12-28
ES8706165A1 (es) 1987-06-01
ES557215A0 (es) 1987-10-01
GB2171100A (en) 1986-08-20
NL8600383A (nl) 1986-09-01
GB8603265D0 (en) 1986-03-19
FR2577556B1 (fr) 1988-01-08
GB8503940D0 (en) 1985-03-20
HU194909B (en) 1988-03-28
IE58864B1 (en) 1993-11-17
SG80890G (en) 1990-11-23
CH669199A5 (de) 1989-02-28
ZA861118B (en) 1986-10-29
DE3604179A1 (de) 1986-08-21
CZ413691A3 (en) 1994-03-16
PT82030A (en) 1986-03-01
FI860672A (fi) 1986-08-16
ES552052A0 (es) 1987-06-01
MY102038A (en) 1992-02-29
AT396239B (de) 1993-07-26
BE904226A (fr) 1986-08-14
IT8619361A1 (it) 1987-08-11
FI84272C (fi) 1991-11-11
FI860672A0 (fi) 1986-02-13
PT82030B (pt) 1988-07-01
NZ215163A (en) 1988-02-29
IT1190335B (it) 1988-02-16
HK94090A (en) 1990-11-23
SE468515B (sv) 1993-02-01
AU577667B2 (en) 1988-09-29
JPS61189295A (ja) 1986-08-22
SE8600668D0 (sv) 1986-02-14
GR860430B (en) 1986-06-12
KR930005994B1 (ko) 1993-07-01

Similar Documents

Publication Publication Date Title
SU1574178A3 (ru) Способ получени производных 4-замещенного андростендиона, или их фармацевтически приемлемых солей
US5616574A (en) Steroid sulphatase inhibitors
SU1442077A3 (ru) Способ получени замещенных андроста-1,4-диен-3,17-дионов
JPH08510455A (ja) １７，２０―リアーゼ阻害活性を有するカルバゾール誘導体
JPS6383095A (ja) ４−置換６−アルキリデンアンドロステン−３，１７−ジオン誘導体およびその製造方法
AU2014300894A1 (en) Therapeutically active 17-nitrogen substituted estratrienthiazole derivatives as inhibitors of 17.beta.-hydroxysteroid dehydrogenase
JPH08510733A (ja) ４−アミノ−１７β−（シクロプロピロキシ）アンドロスト−４−エン−３−オン、４−アミノ−１７β−（シクロプロピルアミノ）アンドロスト−４−エン−３−オン及びＣ▲下１７−２０▼リアーゼ及び５α−レダクターゼ阻害剤としての関連する化合物類
SU1549485A3 (ru) Способ получени производных 6-метиленандроста-1,4-диен-3,17-диона
AU592878B2 (en) New androst-4-ene-3,17-diones and process for their preparation
EP3237431B1 (en) Prodrugs of 17.beta.-hsd1 -inhibitors
IL108632A (en) History Transformed by Fluorine of 4-Aminoandrostadianone, Preparation and Pharmaceutical Preparations Containing Them
SU1540656A3 (ru) Способ получени стероидов или их фармацевтически приемлемых солей
IE59762B1 (en) Indenopyrimidine derivatives
SI9300350A (sl) 17(alfa) in 17(beta)-alkilketon-3-karboksi aromatski A obrocni analogi steroidnih sinteticnih spojin
AU2002342625B2 (en) Methylene-4-azasteroids
HU179980B (en) Process for preparing substituted steroid-spiro-oxazolidinone derivatives
AU769753B2 (en) Steroid sulphatase inhibitors
AU668882C (en) Steroid sulphatase inhibitors
SK286757B6 (sk) 17-Metylénsteroidy, spôsob ich prípravy, farmaceutické kompozície, ktoré ich obsahujú, a ich použitie
AU723707B2 (en) Steroid sulphatase inhibitors
JP2006517947A (ja) 抗腫瘍活性２−置換１８ａ−ホモエストラ−１，３，５（１０）−トリエン−３−イルスルファメート
JPS63222196A (ja) １−メチル−１５α−（１−オキシアルキル）−アンドロスタ−１，４−ジエン−３，１７−ジオン、その製法及びこの化合物を含むエストロゲン生合成抑制剤
GB2195639A (en) Polyconjugated androstenediones and process for their preparation
SI8611201A8 (sl) Postopek za pridobivanje substituiranih androsta -1,4-dien-3,17-dionov